Prime Medicine (PRME) FCF Margin (2024 - 2026)

Prime Medicine posted quarterly FCF Margin of 5014.49% for Q1 2026, down 148773.0% year-on-year from N/an in Q1 2025, and down 26.84% on a QoQ basis from 3953.34% in Q4 2025.

Prime Medicine (PRME) has 3 years of FCF Margin data on file, last reported at 5014.49% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 148773.0% year-over-year to 5014.49%; the trailing twelve-month figure through Mar 2026 stood at 3825.56% (down 108851.0% YoY), and the FY2025 full-year result was 3512.05%, up 64548.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 5014.49%, down from 3953.34% in the prior quarter.
  • Across five years, FCF Margin topped out at 696.38% in Q4 2024 and bottomed at 12281.34% in Q3 2024.
  • The 3-year median for FCF Margin is 3740.05% (2025), against an average of 5329.21%.
  • Peak annual rise in FCF Margin reached 908689 bps in 2025, while the deepest fall reached 464972 bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 696.38% in 2024, then slumped by 668 bps to 3953.34% in 2025, then dropped by 27 bps to 5014.49% in 2026.
  • The last three FCF Margin figures came in at 5014.49% (Q1 2026), 3953.34% (Q4 2025), and 3194.45% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 Prime Medicine 601.24 Mn 601.24 Mn - -5,014.49%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,014.49%
Dec 31, 2025 -3,953.34%
Sep 30, 2025 -3,194.45%
Jun 30, 2025 -3,510.13%
Mar 31, 2025 -3,526.75%
Dec 31, 2024 696.38%
Sep 30, 2024 -12,281.34%
Mar 31, 2024 -11,849.58%